A combined cell therapy and in-situ tissue-engineering approach for myocardial repair

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7514-7523

  Habib, Manhal ^a   Shapira Schweitzer, Keren ^a   Caspi, Oren ^a   Gepstein, Amira ^a   Arbel, Gil ^a   Aronson, Doron ^a   Seliktar, Dror ^a   Gepstein, Lior ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cardiac tissue engineering; Cardiomyocyte; Hydrogel; Stem cells

Indexed keywords

BENEFICIAL EFFECTS; CARDIAC REMODELING; CARDIAC TISSUE ENGINEERING; CARDIOMYOCYTES; CELL LOSS; CELL THERAPY; CO-INJECTION; EMBRYONIC STEMS; FEASIBILITY STUDIES; HYDROGEL MATRIX; IN-SITU; IN-SITU FORMING; MATRIX; NEONATAL RAT; RAT HEART; SALINE-INJECTED CONTROLS;

BIOMOLECULES; ECHOCARDIOGRAPHY; FUNCTIONAL POLYMERS; HYDROGELS; RATS; STEM CELLS; TISSUE;

TISSUE ENGINEERING;

BIOPOLYMER; FIBRINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CELL REGENERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EMBRYO; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; OUTCOME ASSESSMENT; POLYMERIZATION; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; CELLS, CULTURED; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELLS; FIBRINOGEN; HUMANS; HYDROGEL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED F344; TISSUE ENGINEERING; TISSUE THERAPY;

RATTUS;

EID: 80051551893     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.049     Document Type: Article

References (38)

1. Christman K.L., Lee R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006, 48:907-913.
2. Laflamme M.A., Murry C.E. Regenerating the heart. Nat Biotechnol 2005, 23:845-856.
3. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
4. Zimmermann W.H., Didie M., Doker S., Melnychenko I., Naito H., Rogge C., et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006, 71:419-429.
5. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:1163-1169.
6. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006, 12:452-458.
7. Wang F., Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv Drug Deliv Rev 2010, 62:784-797.
8. Wall S.T., Yeh C.C., Tu R.Y., Mann M.J., Healy K.E. Biomimetic matrices for myocardial stabilization and stem cell transplantation. J Biomed Mater Res A 2010, 95:1055-1066.
9. Nelson D.M., Ma Z., Fujimoto K.L., Hashizume R., Wagner W.R. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater 2011, 7:1-15.
10. Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004, 44:654-660.
11. Davis M.E., Motion J.P., Narmoneva D.A., Takahashi T., Hakuno D., Kamm R.D., et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005, 111:442-450.
12. Zhang G., Hu Q., Braunlin E.A., Suggs L.J., Zhang J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 2008, 14:1025-1036.
13. Zhang X., Wang H., Ma X., Adila A., Wang B., Liu F., et al. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Exp Biol Med 2010, 235:1505-1515.
14. Kraehenbuehl T.P., Ferreira L.S., Hayward A.M., Nahrendorf M., van der Vlies A.J., Vasile E., et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011, 32:1102-1109.
15. Ruvinov E., Leor J., Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011, 32:565-578.
16. Garbern J.C., Minami E., Stayton P.S., Murry C.E. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials 2011, 32:2407-2416.
17. Wu J., Zeng F., Huang X.P., Chung J.C., Konecny F., Weisel R.D., et al. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 2011, 32:579-586.
18. Okada M., Payne T.R., Oshima H., Momoi N., Tobita K., Huard J. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 2010, 31:7678-7683.
19. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
20. Hsieh P.C., Davis M.E., Gannon J., MacGillivray C., Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006, 116:237-248.
21. Zhang G., Nakamura Y., Wang X., Hu Q., Suggs L.J., Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007, 13:2063-2071.
22. Almany L., Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005, 26:2467-2477.
23. Shapira K., Dikovsky D., Habib M., Gepstein L., Seliktar D. Hydrogels for cardiac tissue regeneration. Biomed Mater Eng 2008, 18:309-314.
24. Shapira-Schweitzer K., Habib M., Gepstein L., Seliktar D. A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 2009, 46:213-224.
25. Shapira-Schweitzer K., Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater 2007, 3:33-41.
26. Dikovsky D., Bianco-Peled H., Seliktar D. The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials 2006, 27:1496-1506.
27. Dikovsky D., Bianco-Peled H., Seliktar D. Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J 2008, 94:2914-2925.
28. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001, 108:407-414.
29. Peled E., Boss J., Bejar J., Zinman C., Seliktar D. A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J Biomed Mater Res A 2007, 80:874-884.
30. Dow J., Simkhovich B.Z., Kedes L., Kloner R.A. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res 2005, 67:301-307.
31. Muller-Ehmsen J., Whittaker P., Kloner R.A., Dow J.S., Sakoda T., Long T.I., et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002, 34:107-116.
32. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635.
33. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 2005, 46:714-719.
34. Kofidis T., Akhyari P., Wachsmann B., Boublik J., Mueller-Stahl K., Leyh R., et al. A novel bioartificial myocardial tissue and its prospective use in cardiac surgery. Eur J Cardiothorac Surg 2002, 22:238-243.
35. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008, 45:567-581.
36. Frisman I., Orbach R., Seliktar D., Bianco-Peled H. Structural investigation of PEG-fibrinogen conjugates. J Mater Sci Mater Med 2010, 21:73-80.
37. Kehat I., Gepstein L. Human embryonic stem cells for myocardial regeneration. Heart Fail Rev 2003, 8:229-236.
38. Satin J., Itzhaki I., Rapoport S., Schroder E.A., Izu L., Arbel G., et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 2008, 26:1961-1972.